Department of Congenital Heart Disease, Shenyang Northern Hospital, Shenyang 110016, PR China.
Int J Cardiol. 2011 Mar 17;147(3):433-7. doi: 10.1016/j.ijcard.2010.04.093.
Detection of pulmonary vasoreactivity is important for the evaluation of patient with pulmonary arterial hypertension (PAH). The present study aimed to investigate the acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects (CHDs) and severe PAH.
From Mar 2007 to Nov 2009, 75 patients with severe PAH secondary to left-to-right shunt CHDs underwent acute vasodilator test using aerosolized iloprost (n = 50) or intravenous adenosine (n = 25). The hemodynamics were detected and analyzed.
Decreased mean pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) were observed in 39 and 43 patients in the iloprost group, and in 16 and 19 patients in the adenosine group, respectively. However, the mean PAP was higher than 40 mm Hg in both groups. No significant difference was observed in the age and baseline hemodynamics between the patients with the decrease of PVR and mean pulmonary-to-aortic pressure (Pp/Ps) ratio greater than 10% and the remaining patients. Adenosine decreased both PAP and systemic arterial pressure significantly, while iloprost inhalation selectively reduced the PAP and increased the oxygen saturation of femoral arterial blood and the pulmonary-to-systemic flow (Qp/Qs) ratio. Compared with adenosine, iloprost caused a more profound decline in the Pp/Ps ratio, PVR and pulmonary-to-systemic vascular resistance ratio, and increase in the Qp/Qs ratio.
The acute haemodynamic responses to adenosine and iloprost varied among the patients with CHDs and severe PAH. Different to adenosine, inhaled iloprost exerted selective pulmonary vasodilative effects and was beneficial for pulmonary gas exchange.
肺血管反应性的检测对肺动脉高压(PAH)患者的评估非常重要。本研究旨在探讨先天性心脏病(CHD)伴严重 PAH 患者对腺苷和伊洛前列素的急性血液动力学反应。
2007 年 3 月至 2009 年 11 月,75 例由左向右分流 CHD 引起的严重 PAH 患者接受了雾化伊洛前列素(n=50)或静脉内腺苷(n=25)急性血管扩张试验。检测并分析了血液动力学。
伊洛前列素组 39 例和腺苷组 43 例患者的平均肺动脉压(PAP)和肺血管阻力(PVR)降低,但两组患者的平均 PAP 均高于 40mmHg。PVR 和平均肺主动脉压(Pp/Ps)比值降低大于 10%的患者与其余患者在年龄和基础血液动力学方面无显著差异。腺苷显著降低 PAP 和全身动脉压,而伊洛前列素吸入选择性降低 PAP,增加股动脉血氧饱和度和肺-体循环血流量(Qp/Qs)比值。与腺苷相比,伊洛前列素引起的 Pp/Ps 比值、PVR 和肺-体循环血管阻力比值下降更明显,Qp/Qs 比值增加更明显。
CHD 伴严重 PAH 患者对腺苷和伊洛前列素的急性血液动力学反应不同。与腺苷不同,吸入伊洛前列素对肺血管有选择性扩张作用,有利于肺气体交换。